advanced search
Dr HongmingChen

Is this your profile?

About

Hongming Chen, ScD, was was Chief Scientific Officer of Kala Pharmaceuticals (now Kala Bio) until 2021.

Contributions

OCULAR
BREAKTHROUGH NANOTECHNOLOGY ENHANCES DELIVERY TO THE FRONT AND BACK OF THE EYE
Hongming Chen and Robert Langer discuss applications of the company’s Mucus Penetrating Particle nanotechnology in ophthalmic drug delivery.
Top